When Is An iPad More Than An iPad? When It Is An FDA Regulated Medical Device

by Pepper Hamilton LLP
Contact

In the late 1980s, the Food and Drug Administration (FDA) began publicly suggesting that electronic medical records were within its jurisdiction. A lot has changed in 20+ years. The proliferation of mobile computing platforms and the applications they run has exploded. Health care providers have access to technology that was the stuff of science fiction in 1989, and health care consumers can track their own health status and records with the swipe of a finger. On September 25, 2013, the FDA finally made its stand, issuing a Final Guidance on Mobile Medical Applications.1 FDA has approved to date about 100 mobile medical applications which focus, generally, on chronic condition management.2

So, if you’ve ever wondered whether an iPad running a “health app” is a regulated “medical device,” the FDA has now provided an analytical framework for answering this and other burning mobile-app-related questions. Of course, the answer depends on the nature, functionality and intended use of the application.

The Guidance begins with a number of definitions, including:

Mobile Platform: Commercial off-the-shelf computing platforms, with or without wireless connectivity, that are handheld in nature.

Mobile Application (App): A software application that can be executed (run) on a mobile platform, or a Web-based software application that is tailored to a mobile platform but is executed on a server.

Mobile Medical Application: A Mobile App that meets the statutory definition of a “device” and either is intended:

  • to be used as an accessory to a regulated medical device, or
  • to transform a mobile platform into a medical device.

Pepper Point: Whether or not a Mobile App is a “device” depends upon its intended use. An application that is not designed/developed/marketed for a health care use is not a “device,” and thus not subject to FDA regulation.

The Guidance separates mobile applications into three somewhat distinct categories, each of which potentially could be downloaded to an iPad and used in a clinical setting. Those categories are:

  1. Mobile Apps that are considered medical devices, and which the FDA intends to regulate
  2. Mobile Apps that may be considered medical devices, but which the FDA does not currently intend to regulate, and
  3. Mobile Apps that could be used in a healthcare environment, but are not considered medical devices.

The FDA has provided a fairly lengthy list of examples of each of these three categories. A few of those examples are:

  1. Medical Devices/Regulated (generally, functionality that directly affects a patient’s care or provides patient-specific analysis, diagnosis, etc.):
  • applications that are intended to be used as an accessory to a medical device, connect to and control medical devices, or display, store, analyze or transmit patient-specific medical device data (i.e., direct or remote control of insulin pumps or blood pressure cuffs, or remote display of data from bedside monitors)
  • applications that transform the mobile platform into a medical device with attachments, sensors, etc. (i.e., attachment of a blood glucose strip meter), and
  • applications that perform patient-specific analysis, diagnosis, etc. (i.e., to calculate dosage or create a dosage plan for radiation therapy).
  1. May Be Medical Devices/Not Currently Regulated (generally, information or functionality that may relate to a specific patient’s diagnosis or treatment, but which pose a low risk to the public):
  • applications that provide periodic educational or other information to help individuals self-manage a specific condition (i.e., smokers, recovering addicts, asthmatics, diabetics)
  • applications that track and store user-entered health data (i.e., asthmatics, diabetics, medication information, fitness) and communicate with health care providers
  • checklists of common signs and symptoms to provide advice on when to consult a physician, and 
  • applications that automate basic tasks for health care providers.
  1. Not Medical Devices (generally, no information/functionality that relates to a specific patient’s diagnosis or treatment):
  • electronic copies of reference materials
  • educational tools such as interactive anatomy diagrams, and 
  • applications used for general patient education, such as information about gluten-free food products.

The FDA exercises its mandate of consumer product safety through processes by which it obtains assurance from manufacturers that the medical device is safe and effective. While most mobile medical applications subject to the FDA will be Class I or II and exempt from 510(k) pre-market approval requirements, these applications must still:

  • be suitable for their intended use
  • be adequately packaged and properly labeled
  • have establishment registration and device listing forms on file with the FDA, and  
  • be manufactured under a quality system (with the exception of a small number of Class I devices that are subject only to complaint files and general recordkeeping requirements).

Pepper Point: If you are developing a new Mobile App and think it might fall under the “regulated” category, make sure to follow the above practices. It is easier to build such processes into the product launch from the beginning than retrofitting the application later.

Conclusion

The convergence of regulations surrounding mobile medical applications can be complex. An iPad could be used in a clinical setting with multiple apps on it, some of which transform it into a medical device and others that do not. Even if the mobile application is not currently subject to FDA regulation, the content of the application may trigger obligations under other regulations such as the FTC and/or HIPAA/HITECH.3

Endnotes

1 Food and Drug Administration, Mobile Medical Applications: Guidance for Industry and Food and Drug Administration Staff, September 25, 2013. Can be found at: http://www.fda.gov/downloads/MedicalDevices/.../UCM263366.pdf.

2 “Patient Apps for Improved Healthcare – From Novelty to Mainstream,” IMS Institute for Healthcare Informatics, October 2013.

3 For further reading, please see the following Pepper Hamilton LLP Client Alerts: "FTC Recommends Framework for Mobile Privacy" (February 25, 2013), available at http://www.pepperlaw.com/publications_update.aspx?ArticleKey=2564; "California Privacy Initiatives Go into Effect January 1, 2014 - Are You Ready?" (November 19, 2013), available at http://www.pepperlaw.com/publications_update.aspx?ArticleKey=2795; and "The FDA Gets Social: Interpreting Its Draft Social Media Guidance" (January 27, 2014), available at http://www.pepperlaw.com/publications_update.aspx?ArticleKey=2836.

Written by:

Pepper Hamilton LLP
Contact
more
less

Pepper Hamilton LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
Feedback? Tell us what you think of the new jdsupra.com!